Citations 1
P56 SURVIVAL BENEFIT OF BIRTAMIMAB IN MAYO STAGE IV AL AMYLOIDOSIS IN THE PHASE 3 VITAL STUDY WAS CONSISTENT ACROSS ALL KEY BASELINE VARIABLES
Comenzo, Raymond L. , Landau, Heather , Libby, Edward N., Liedtke, Michaela , Wechalekar, Ashutosh , Zonder, Jeffrey A. , Nie, C. , Karp, Carol L. , Jin, Yu , Conrad, Anne , Kinney, Gene G. , Gertz, Morie A. , Cohen, Adam D. , Kastritis, Efstathios , Sanchorawala, Vaishali , Schönland, Stefan , Wechalekar, Ashutosh D. , Ando, Yukio , Koh, Youngil , Palladini, Giovanni , Karp, C., Conrad, A., Merlini, Giampaolo
HemaSphere | May 11, 2023 | Volume: 7 | Issue: S2 | Pages: 41-42
